- 期刊
- OpenAccess
Stem Cell-Derivative Improves Parkinson's Disease
摘要
Five years ago, a 63-year-old woman was diagnosed with Parkinson's disease (PD) with right upper limb tremor. Right lower limb tremor was noted in the last 2 years. Drugs, including a monoamine oxidase type B (MAO-B) inhibitor, an anticholinergic agent, and amantadine, were administered for 3 years, but the patient's improvement was limited. TELOXOME, a novel stem cell-derived agent produced by ContiNew Medical, was intravenously infused weekly. Subsequently, lower limb tremor disappeared and upper limb tremor also diminished after the treatment with 4 doses of TELOXOME. The patient's levels of plasma Cyfra21-1, lactate dehydrogenase (LDH), and tumor necrosis factor-α (TNF-α) were high before treatment but returned to the normal range after 4 infusions.
關鍵字
TELOXOME延伸閱讀
- Zheng, Y., Huang, J., Zhu, T., Li, R., Wang, Z., Ma, F., & Zhu, J. (2017). Stem Cell Tracking Technologies for Neurological Regenerative Medicine Purposes. Stem Cells International, 2017(), 1-9-63. https://doi.org/10.1155/2017/2934149
- Denyer, R., & Douglas, M. R. (2012). Gene Therapy for Parkinson's Disease. Parkinson＇s Disease, 2012(), 600-612. https://doi.org/10.1155/2012/757305
- 蔣漢琳（2023）。Parkinson's Disease Treatment and New Drugs Development。台灣醫學，27(2)，180-186。https://doi.org/10.6320/FJM.202303_27(2).0008
- 馮清榮、蔡女滿、徐偉成、韓鴻志、林欣榮（2003）。An Introduction to Stem Cell Research。志為護理-慈濟護理雜誌，2(1)，7-12。https://doi.org/10.6974/TCNJ.200303.0007
- 林欣榮（1997）。Neural Transplantation for Parkinson's Disease。台灣醫學，1(3)，333-338。https://doi.org/10.6320/FJM.1997.1(3).10